<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36769169</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>02</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Functional Characterization of a Familial ALS-Associated Missense <i>TBK1</i> (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2847</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24032847</ELocationID><Abstract><AbstractText>The goal of this work was to elucidate the pathogenic mechanism of an ALS-associated missense mutation, p.Arg573Gly (R573G), in the <i>TBK1</i> gene. In particular, we seek to analyze the influence of this variant on the cellular levels and the function of TBK1 in immortalized cells from an ALS patient. The patient (Code# E7) belonged to a Spanish family with autosomal dominant disease manifesting in the sixth decade as either dementia or ALS. Four control individuals without signs of neurological disease were also included in this study. Our results indicate that the R375G <i>TBK1</i> mutation did not affect the levels of mRNA nor the total TBK1 content; however, we observed a significant decrease in the levels of TBK1 phosphorylation, which is essential for TBK1 activity, as well as a significant reduction in the phosphorylation of p62 and RIPK1, known substrates for TBK1. Lymphoblasts from the R573G <i>TBK1</i> mutation carrier patient display pathological TDP-43 homeostasis, showing elevated levels of phosphorylated TDP-43 and accumulation of the protein in the cytosolic compartment. In addition, the functional decrease in TBK1 activity observed in the E7 patient did not alter the autophagy flux, but it seems to be enough to increase ROS levels as well as the expression of pro-inflammatory cytokine IL-6.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Porras</LastName><ForeName>Gracia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Molecular Biomedicine, Centro de Investigaciones Biol&#xf3;gicas, Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Silvana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Biomedicine, Centro de Investigaciones Biol&#xf3;gicas, Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maestro</LastName><ForeName>In&#xe9;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Structural and Chemical Biology, Centro de Investigaciones Biol&#xf3;gicas, Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borrego-Hern&#xe1;ndez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>ALS Research Lab, Hospital 12 de Octubre Research Institute (i+12), 28041 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redondo</LastName><ForeName>Alberto G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0001-7646-386X</Identifier><AffiliationInfo><Affiliation>ALS Research Lab, Hospital 12 de Octubre Research Institute (i+12), 28041 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2707-8110</Identifier><AffiliationInfo><Affiliation>Department of Structural and Chemical Biology, Centro de Investigaciones Biol&#xf3;gicas, Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Requero</LastName><ForeName>&#xc1;ngeles</ForeName><Initials>&#xc1;</Initials><Identifier Source="ORCID">0000-0002-3416-9440</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biomedicine, Centro de Investigaciones Biol&#xf3;gicas, Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CB18/05/00040</GrantID><Agency>Biomedical Research Networking Center on Neurodegenerative Diseases</Agency><Country/></Grant><Grant><GrantID>RTI2018-096100-B-I00 and PID2019-105600RB-I00</GrantID><Agency>Agencia Estal de Investigaci&#xf3;n</Agency><Country/></Grant><Grant><GrantID>B2017/BMD-3813</GrantID><Agency>Comunidad de Madrid</Agency><Country/></Grant><Grant><GrantID>HR21-00931</GrantID><Agency>Fundacion la Caixa-Luz&#xf3;n</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C403191">TBK1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RIPK1</Keyword><Keyword MajorTopicYN="N">TBK1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">lymphoblasts</Keyword></KeywordList><CoiStatement>The authors have no relevant interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>1</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36769169</ArticleId><ArticleId IdType="pmc">PMC9917786</ArticleId><ArticleId IdType="doi">10.3390/ijms24032847</ArticleId><ArticleId IdType="pii">ijms24032847</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zarei S., Carr K., Reiley L., Diaz K., Guerra O., Altamirano P.F., Pagani W., Lodin D., Orozco G., Chinea A. A Comprehensive Review of Amyotrophic Lateral Sclerosis. Surg. Neurol. Int. 2015;6:171. doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic Lateral Sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A., Xu Z., Hayward L.J. Aberrantly Increased Hydrophobicity Shared by Mutants of Cu,Zn-Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis. J. Biol. Chem. 2005;280:29771&#x2013;29779. doi: 10.1074/jbc.M504039200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M504039200</ArticleId><ArticleId IdType="pubmed">15958382</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From Genes to Mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.-F., Wang Q., Krueger B.J., et al. Exome Sequencing in Amyotrophic Lateral Sclerosis Identifies Risk Genes and Pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>le Ber I., de Septenville A., Millecamps S., Camuzat A., Caroppo P., Couratier P., Blanc F., Lacomblez L., Sellal F., Fleury M.-C., et al. TBK1 Mutation Frequencies in French Frontotemporal Dementia and Amyotrophic Lateral Sclerosis Cohorts. Neurobiol. Aging. 2015;36:3116.e5&#x2013;3116.e8. doi: 10.1016/j.neurobiolaging.2015.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.009</ArticleId><ArticleId IdType="pubmed">26476236</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes J.A., Davies M.C., Collins M.O. TBK1: A New Player in ALS Linking Autophagy and Neuroinflammation. Mol. Brain. 2017;10:5. doi: 10.1186/s13041-017-0287-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J., Cheung J., Gerbino V., Ahls&#xe9;n G., Zimanyi C., Hirsh D., Maniatis T. Effects of ALS-Associated TANK Binding Kinase 1 Mutations on Protein&#x2013;Protein Interactions and Kinase Activity. Proc. Natl. Acad. Sci. USA. 2019;116:24517&#x2013;24526. doi: 10.1073/pnas.1915732116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1915732116</ArticleId><ArticleId IdType="pmc">PMC6900539</ArticleId><ArticleId IdType="pubmed">31748271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Helgason E., Phung Q.T., Quan C.L., Iyer R.S., Lee M.W., Bowman K.K., Starovasnik M.A., Dueber E.C. Molecular Basis of Tank-Binding Kinase 1 Activation by Transautophosphorylation. Proc. Natl. Acad. Sci. USA. 2012;109:9378&#x2013;9383. doi: 10.1073/pnas.1121552109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1121552109</ArticleId><ArticleId IdType="pmc">PMC3386122</ArticleId><ArticleId IdType="pubmed">22619329</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu D., Zhu Z., Zhou A.Y., Yun C., Lee K.-E., Toms A.V., Li Y., Dunn G.P., Chan E., Thai T., et al. Structure and Ubiquitination-Dependent Activation of TANK-Binding Kinase 1. Cell Rep. 2013;3:747&#x2013;758. doi: 10.1016/j.celrep.2013.01.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.01.033</ArticleId><ArticleId IdType="pmc">PMC3863638</ArticleId><ArticleId IdType="pubmed">23453972</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., H&#xfc;bers A., Weydt P., et al. Haploinsufficiency of TBK1 Causes Familial ALS and Fronto-Temporal Dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>de Majo M., Topp S.D., Smith B.N., Nishimura A.L., Chen H.-J., Gkazi A.S., Miller J., Wong C.H., Vance C., Baas F., et al. ALS-Associated Missense and Nonsense TBK1 Mutations Can Both Cause Loss of Kinase Function. Neurobiol. Aging. 2018;71:266.e1&#x2013;266.e10. doi: 10.1016/j.neurobiolaging.2018.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.015</ArticleId><ArticleId IdType="pmc">PMC6983933</ArticleId><ArticleId IdType="pubmed">30033073</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Tortosa E., van der Zee J., Ruggiero M., Gijselinck I., Esteban-P&#xe9;rez J., Garc&#xed;a-Redondo A., Borrego-Hern&#xe1;ndez D., Navarro E., Sainz M.J., P&#xe9;rez-P&#xe9;rez J., et al. Familial Primary Lateral Sclerosis or Dementia Associated with Arg573Gly TBK1 Mutation. J. Neurol. Neurosurg. Psychiatry. 2017;88:996&#x2013;997. doi: 10.1136/jnnp-2016-315250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315250</ArticleId><ArticleId IdType="pubmed">28365590</ArticleId></ArticleIdList></Reference><Reference><Citation>Posa D., Mart&#xed;nez-Gonz&#xe1;lez L., Bartolom&#xe9; F., Nagaraj S., Porras G., Mart&#xed;nez A., Mart&#xed;n-Requero &#xc1;. Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients. Mol. Neurobiol. 2018;56:2424&#x2013;2432. doi: 10.1007/s12035-018-1249-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1249-8</ArticleId><ArticleId IdType="pubmed">30030753</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Gonz&#xe1;lez L., Rodr&#xed;guez-Cueto C., Cabezudo D., Bartolom&#xe9; F., Andr&#xe9;s-Benito P., Ferrer I., Gil C., Mart&#xed;n-Requero &#xc1;., Fern&#xe1;ndez-Ruiz J., Mart&#xed;nez A., et al. Motor Neuron Preservation and Decrease of in Vivo TDP-43 Phosphorylation by Protein CK-1&#x3b4; Kinase Inhibitor Treatment. Sci. Rep. 2020;10:4449. doi: 10.1038/s41598-020-61265-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-61265-y</ArticleId><ArticleId IdType="pmc">PMC7064575</ArticleId><ArticleId IdType="pubmed">32157143</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Cheng X., Zhong S., Zhang X., Liu C., Liu F., Zhao C. Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis. Front. Neurosci. 2020;14:575. doi: 10.3389/fnins.2020.00575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00575</ArticleId><ArticleId IdType="pmc">PMC7308438</ArticleId><ArticleId IdType="pubmed">32612503</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The Changing Scene of Amyotrophic Lateral Sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G., Shimogori T., Hattori N., Nukina N. TBK1 Controls Autophagosomal Engulfment of Polyubiquitinated Mitochondria through P62/SQSTM1 Phosphorylation. Hum. Mol. Genet. 2015;24:4429&#x2013;4442. doi: 10.1093/hmg/ddv179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv179</ArticleId><ArticleId IdType="pubmed">25972374</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng J., Ito Y., Shi L., Amin P., Chu J., Ouchida A.T., Mookhtiar A.K., Zhao H., Xu D., Shan B., et al. Regulation of RIPK1 Activation by TAK1-Mediated Phosphorylation Dictates Apoptosis and Necroptosis. Nat. Commun. 2017;8:359. doi: 10.1038/s41467-017-00406-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00406-w</ArticleId><ArticleId IdType="pmc">PMC5572456</ArticleId><ArticleId IdType="pubmed">28842570</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Chen H.J., Shaw C.E. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics. 2015;12:352&#x2013;363. doi: 10.1007/s13311-015-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauthe M., Orhon I., Rocchi C., Zhou X., Luhr M., Hijlkema K.J., Coppes R.P., Engedal N., Mari M., Reggiori F. Chloroquine Inhibits Autophagic Flux by Decreasing Autophagosome-Lysosome Fusion. Autophagy. 2018;14:1435&#x2013;1455. doi: 10.1080/15548627.2018.1474314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1474314</ArticleId><ArticleId IdType="pmc">PMC6103682</ArticleId><ArticleId IdType="pubmed">29940786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Cleveland D.W. Tuning Apoptosis and Neuroinflammation: TBK1 Restrains RIPK1. Cell. 2018;174:1339&#x2013;1341. doi: 10.1016/j.cell.2018.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.08.035</ArticleId><ArticleId IdType="pubmed">30193106</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Shaw P.J. Oxidative Stress in ALS: Key Role in Motor Neuron Injury and Therapeutic Target. Free Radic. Biol. Med. 2010;48:629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lastres-Becker I., Porras G., Arribas-Bl&#xe1;zquez M., Maestro I., Borrego-Hern&#xe1;ndez D., Boya P., Cerd&#xe1;n S., Garc&#xed;a-Redondo A., Mart&#xed;nez A., Martin-Requero &#xc1;. Molecular Alterations in Sporadic and Sod1-Als Immortalized Lymphocytes: Towards a Personalized Therapy. Int. J. Mol. Sci. 2021;22:3007. doi: 10.3390/ijms22063007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063007</ArticleId><ArticleId IdType="pmc">PMC8000750</ArticleId><ArticleId IdType="pubmed">33809456</ArticleId></ArticleIdList></Reference><Reference><Citation>Said Ahmed M., Hung W.-Y., Zu J.S., Hockberger P., Siddique T. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1. J. Neurol. Sci. 2000;176:88&#x2013;94. doi: 10.1016/S0022-510X(00)00317-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00317-8</ArticleId><ArticleId IdType="pubmed">10930589</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Colombrita C., Gumina V., Borghi M.O., Dusi S., Doretti A., Fagiolari G., Invernizzi F., Moggio M., Tiranti V., et al. Gene-Specific Mitochondria Dysfunctions in Human TARDBP and C9ORF72 Fibroblasts. Acta Neuropathol. Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A., Rademakers R. The Role of Transactive Response DNA-Binding Protein-43 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Curr. Opin. Neurol. 2008;21:693&#x2013;700. doi: 10.1097/WCO.0b013e3283168d1d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e3283168d1d</ArticleId><ArticleId IdType="pmc">PMC2869081</ArticleId><ArticleId IdType="pubmed">18989115</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaca G., Martinez-Gonzalez L., Fernandez A., Rojas-Prats E., Porras G., Cuevas E.P., Gil C., Martinez A., Martin-Requero &#xc1;. Therapeutic Potential of Novel Cell Division Cycle Kinase 7 Inhibitors on TDP-43-Related Pathogenesis Such as Frontotemporal Lobar Degeneration (FTLD) and Amyotrophic Lateral Sclerosis (ALS) J. Neurochem. 2021;156:379&#x2013;390. doi: 10.1111/jnc.15118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15118</ArticleId><ArticleId IdType="pubmed">32628315</ArticleId></ArticleIdList></Reference><Reference><Citation>de Marco G., Lupino E., Calvo A., Moglia C., Buccinn&#xe0; B., Grifoni S., Ramondetti C., Lomartire A., Rinaudo M.T., Piccinini M., et al. Cytoplasmic Accumulation of TDP-43 in Circulating Lymphomonocytes of ALS Patients with and without TARDBP Mutations. Acta Neuropathol. 2011;121:611&#x2013;622. doi: 10.1007/s00401-010-0786-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0786-7</ArticleId><ArticleId IdType="pubmed">21120508</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W., Guo M., Yi L., Zhang J., Bi Y., Liu Y., Li Y., Li Z., Ma Y., Zhang G., et al. Deletion of Tbk1 disrupts autophagy and reproduces behavioral and locomotor symptoms of FTD-ALS in mice. Aging. 2019;11:2457&#x2013;2476. doi: 10.18632/aging.101936.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101936</ArticleId><ArticleId IdType="pmc">PMC6519994</ArticleId><ArticleId IdType="pubmed">31039129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad L., Zhang S.Y., Casanova J.L., Sancho-Shimizu V. Human TBK1: A Gatekeeper of Neuroinflammation. Trends Mol. Med. 2016;22:511&#x2013;527. doi: 10.1016/j.molmed.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4890605</ArticleId><ArticleId IdType="pubmed">27211305</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafont E., Draber P., Rieser E., Reichert M., Kupka S., de Miguel D., Draberova H., von M&#xe4;ssenhausen A., Bhamra A., Henderson S., et al. TBK1 and IKK&#x3b5; Prevent TNF-Induced Cell Death by RIPK1 Phosphorylation. Nat. Cell Biol. 2018;20:1389&#x2013;1399. doi: 10.1038/s41556-018-0229-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0229-6</ArticleId><ArticleId IdType="pmc">PMC6268100</ArticleId><ArticleId IdType="pubmed">30420664</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., Jin T., Zhu H., Chen H., Ofengeim D., Zou C., Mifflin L., Pan L., Amin P., Li W., et al. TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging. Cell. 2018;174:1477&#x2013;1491.e19. doi: 10.1016/j.cell.2018.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.041</ArticleId><ArticleId IdType="pmc">PMC6128749</ArticleId><ArticleId IdType="pubmed">30146158</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q., Sammut B., Wang F.M., Kurihara N., Windle J.J., Roodman G.D., Galson D.L. TBK1 Mediates Critical Effects of Measles Virus Nucleocapsid Protein (MVNP) on Pagetic Osteoclast Formation. J. Bone Miner. Res. 2014;29:90&#x2013;102. doi: 10.1002/jbmr.2026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.2026</ArticleId><ArticleId IdType="pmc">PMC3870038</ArticleId><ArticleId IdType="pubmed">23794264</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R., Zecca C., Piccininni M., Benmahamed S., Dell&#x2019;Abate M.T., Barulli M.R., Capozzo R., Battista P., Logroscino G. Plasma Inflammatory Cytokines Are Elevated in ALS. Front. Neurol. 2020;11:552295. doi: 10.3389/fneur.2020.552295.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.552295</ArticleId><ArticleId IdType="pmc">PMC7691268</ArticleId><ArticleId IdType="pubmed">33281700</ArticleId></ArticleIdList></Reference><Reference><Citation>Pronto-Laborinho A., Pinto S., Gromicho M., Pereira M., Swash M., de Carvalho M. Interleukin-6 and Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2019;398:50&#x2013;53. doi: 10.1016/j.jns.2019.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.01.026</ArticleId><ArticleId IdType="pubmed">30682521</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Denizot F., Lang R. Rapid Colorimetric Assay for Cell Growth and Survival: Modifications to the Tetrazolium Dye Procedure Giving Improved Sensitivity and Reliability. J. Immunol. Mrthods. 1986;89:271&#x2013;277. doi: 10.1016/0022-1759(86)90368-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(86)90368-6</ArticleId><ArticleId IdType="pubmed">3486233</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquezar C., Salado I.G., de La Encarnaci&#xf3;n A., P&#xe9;rez D.I., Moreno F., Gil C., de Munain A.L., Mart&#xed;nez A., Mart&#xed;n-Requero &#xc1;. Targeting TDP-43 Phosphorylation by Casein Kinase-1&#x3b4; Inhibitors: A Novel Strategy for the Treatment of Frontotemporal Dementia. Mol. Neurodegener. 2016;11:1&#x2013;14. doi: 10.1186/s13024-016-0102-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0102-7</ArticleId><ArticleId IdType="pmc">PMC4852436</ArticleId><ArticleId IdType="pubmed">27138926</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>